OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem
Attika Rehman, Wayne M. Patrick, Iain L. Lamont
Journal of Medical Microbiology (2019) Vol. 68, Iss. 1, pp. 1-10
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies
R Frèdi Langendonk, Daniel R. Neill, Joanne L. Fothergill
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 154

The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic
Aref Shariati, Maniya Arshadi, Mohammad Ali Khosrojerdi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 135

The Advances in Biomedical Applications of Carbon Nanotubes
Timur Saliev
C – Journal of Carbon Research (2019) Vol. 5, Iss. 2, pp. 29-29
Open Access | Times Cited: 105

Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
Chiara Rezzoagli, Martina Archetti, Ingrid Mignot, et al.
PLoS Biology (2020) Vol. 18, Iss. 8, pp. e3000805-e3000805
Open Access | Times Cited: 95

Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region
Mahmood Al-Orphaly, Hamad Abdel Hadi, Faiha Eltayeb, et al.
mSphere (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 84

Predictable properties of fitness landscapes induced by adaptational tradeoffs
Suman G. Das, S. Direito, Bartłomiej Wacław, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 71

Mechanism of action, resistance, synergism, and clinical implications of azithromycin
Mohsen Heidary, Ahmad Ebrahimi Samangani, Abolfazl Kargari, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 6
Open Access | Times Cited: 68

Compensatory evolution of Pseudomonas aeruginosa’s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis
Ruggero La Rosa, Elio Rossi, Adam M. Feist, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 58

Antimicrobial Photodynamic Therapy for the Remote Eradication of Bacteria
Evelias Yan, Germain Kwek, Ng Shuang Qing, et al.
ChemPlusChem (2023) Vol. 88, Iss. 3
Open Access | Times Cited: 29

Tackling antibiotic resistance by inducing transient and robust collateral sensitivity
Sara Hernando‐Amado, Pablo Laborda, José Luis Martínez
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28

Overcoming the Oxygen Dilemma in Photoredox Catalysis: Near‐Infrared (NIR) Light‐Triggered Peroxynitrite Generation for Antibacterial Applications
Zhiqiang Shen, Shaoqiu Zheng, Yuanmeng Fang, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 20
Open Access | Times Cited: 25

Structure-function-guided design of synthetic peptides with anti-infective activity derived from wasp venom
Andreia Boaro, Lucía Ageitos, Marcelo D. T. Torres, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 7, pp. 101459-101459
Open Access | Times Cited: 25

A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics
Franziska Kampshoff, Mark Willcox, Debarun Dutta
Antibiotics (2019) Vol. 8, Iss. 2, pp. 60-60
Open Access | Times Cited: 58

Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections
Shihui Yu, Shaoning Wang, Peizhi Zou, et al.
International Journal of Pharmaceutics (2019) Vol. 575, pp. 118915-118915
Open Access | Times Cited: 57

Different Nanotechnology Approaches for Ciprofloxacin Delivery Against Multidrug-Resistant Microbes
Ashagrachew Tewabe Yayehrad, Gebremariam Birhanu Wondie, Tesfa Marew
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 413-426
Open Access | Times Cited: 34

Royal Jelly as a Nutraceutical Natural Product with a Focus on Its Antibacterial Activity
Lilla Bagameri, Gabriela-Maria Baci, Daniel Severus Dezmirean
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1142-1142
Open Access | Times Cited: 30

Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections
Joshua C. Nwabuife, Calvin A. Omolo, Thirumala Govender
Journal of Controlled Release (2022) Vol. 349, pp. 338-353
Closed Access | Times Cited: 30

Antibiotic resistance of Pseudomonas aeruginosa isolated from hospital wastewater in the Czech Republic
Nikola Roulová, Petra Moťková, Iveta Brožková, et al.
Journal of Water and Health (2022) Vol. 20, Iss. 4, pp. 692-701
Open Access | Times Cited: 29

Mutational background influencesP. aeruginosaciprofloxacin resistance evolution but preserves collateral sensitivity robustness
Sara Hernando‐Amado, Pablo Laborda, Jósé R. Valverde, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 15
Open Access | Times Cited: 29

Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high‐quality research
Junko Takata, Michael E. Hopkins, Victoria Alexander, et al.
Clinical Otolaryngology (2023) Vol. 48, Iss. 3, pp. 381-394
Open Access | Times Cited: 18

The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance
Marwa N. Ahmed, Ahmed Abdelsamad, Tina Wassermann, et al.
npj Biofilms and Microbiomes (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 44

The Role of Proteomics in Bacterial Response to Antibiotics
Foteini Tsakou, Rosa Jersie-Christensen, Håvard Jenssen, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 214-214
Open Access | Times Cited: 41

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant Pseudomonas aeruginosa in Clinical Settings
Frank R. Jones, Yanmin Hu, Anthony Coates
Antibiotics (2022) Vol. 11, Iss. 3, pp. 323-323
Open Access | Times Cited: 24

Can We Arrest the Evolution of Antibiotic Resistance? The Differences between the Effects of Silver Nanoparticles and Silver Ions
Huiru Zhao, Meiling Wang, Yueting Cui, et al.
Environmental Science & Technology (2022) Vol. 56, Iss. 8, pp. 5090-5101
Closed Access | Times Cited: 22

Page 1 - Next Page

Scroll to top